Note · Research
CPHI Korea 2026: An Early Look at Seoul's Premier Pharma and Bio Event
The global pharmaceutical and biotechnology landscape continues its dynamic evolution, with South Korea emerging as a pivotal hub for innovation and business development. Against this backdrop, CPHI Korea 2026, co-located with Hi Korea 2026, stands out as a critical event for industry professionals seeking to connect, collaborate, and identify new opportunities. Organized by Informa Markets, this exhibition is scheduled to take place from August 25-27, 2026, at the COEX Convention & Exhibition Center in Seoul.
As a prominent business-to-business (B2B) platform, CPHI Korea focuses on the entire pharmaceutical supply chain, alongside the rapidly expanding bio and nutraceutical sectors. It promises to be a comprehensive showcase of the latest advancements and market trends, drawing a diverse array of participants from across the globe.
To provide a clear overview of the event's primary organizer, Informa Markets, we've compiled key details:
| Organizer | Headquarters | Founded | Flagship Industry Events (Medical/Pharma Focus) |
|---|---|---|---|
| Informa Markets | London, UK | 1998 | CPHI series (e.g., CPHI Korea, CPHI Worldwide), Hi series (e.g., Hi Korea), Arab Health |
Navigating the CPHI Korea 2026 Exhibition Floor
CPHI Korea 2026 is designed to offer a deep dive into the multifaceted world of pharmaceutical manufacturing and supply. The exhibition's scope is remarkably broad, encompassing active pharmaceutical ingredients (APIs), excipients, and finished dosage forms. Beyond these core components, attendees can explore innovations in biopharmaceuticals, contract manufacturing and research services, and essential regulatory and laboratory equipment.
Furthermore, the event will highlight advancements in packaging solutions and drug-delivery systems, reflecting the industry's continuous drive for efficiency and patient safety. With projections indicating over 500 exhibitors and an anticipated 20,000 attendees, the event floor at COEX will be a bustling marketplace of ideas and commerce. An early exhibitor directory even suggests a potential for up to 924 exhibiting companies, underscoring the event's growing significance.
Early Exhibitor Spotlight: Zhejiang Delekang Food Co., Ltd.
Among the companies already signaling their participation, Zhejiang Delekang Food Co., Ltd. stands out. Their early commitment to CPHI Korea 2026 highlights the event's appeal to a wide range of suppliers within the pharmaceutical and nutraceutical value chain. Such early confirmations provide a glimpse into the caliber and diversity of companies that will be showcasing their products and services, from raw material providers to specialized solution developers.
Strategic Opportunities and Market Insights
For both domestic and international companies, CPHI Korea 2026 offers unparalleled strategic opportunities. The event serves as a vital platform for forging new partnerships, securing critical supply agreements, and exploring outsourcing solutions tailored to the dynamic South Korean pharmaceutical and biotech market. The ability to connect directly with a vast network of buyers and suppliers in one location is a significant advantage for business development.
Beyond direct business interactions, CPHI Korea is also a hub for knowledge exchange. Co-located seminars and conferences will provide attendees with critical insights into emerging market trends, regulatory updates, and pressing industry issues. These educational components are invaluable for staying competitive and informed in a fast-evolving sector, making the event a holistic experience for professional growth and strategic planning.